Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA

Corporate Breaking News

Home : Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA

Apr 16 2020	Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
ADELAIDE, Australia and LIEGE, Belgium, April 16, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) today announced that Mayne Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA),...


Source:https://www.prnewswire.com:443/news-releases/mayne-pharma-submits-new-drug-application-for-e4drsp-to-the-fda-301041620.html

Related News
» X Financial Postpones Fourth Quarter and Fiscal Year 2019 Financial Results to April 28, 2020 » Pintec Joins Hands with International Technology Giants to Set Up Innovation Center for the Adoption of Robotic Process Automation in Financial Market